High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase

Cancer Research

Volumn 61, Issue 5, 2001, Pages 2189-2193

  Boulay, Anne ^a   Masson, Régis ^a   Chenard, Marie Pierre ^b   El Fahime, Mostapha ^a   Cassard, Lydie ^c   Bellocq, Jean Pierre ^b   Sautès Fridman, Catherine ^c   Basset, Paul ^a   Rio, Marie Christine ^a  

^a CNRS   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; STROMELYSIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DEATH; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CELL DIVISION; COLONIC NEOPLASMS; INBREEDING; MACROPHAGES; MATRIX METALLOPROTEINASE 11; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS;

EID: 0035266386     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Suppression of Ice and apoptosis in mammary epithelial cells by extracellular matrix
2. Stromal cell expression of components of matrix-degrading protease systems in human cancer
3. Emerging roles for proteinases in cancer
4. Proteases and cancer invasion: From belief to certainty
5. Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland
6. ECM signaling: Orchestrating cell behavior and misbehavior
7. Stromelysin-3: A paradigm for stroma-derived factors implicated in carcinoma progression
8. Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutical implications
9. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3
10. Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3
11. The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase
12. Furin-dependent intracellular activation of the human stromelysin-3 zymogen
13. Developmental expression of mouse stromelysin-3 mRNA
14. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis
15. Rat stromelysin-3: Cdna cloning from healing skin wound, activation by furin, and expression in rat tissues
16. Thyroid hormone-induced gene expression program for amphibian tail resorption
17. Stromelysin-3 in the biology of the normal and neoplastic mammary gland
18. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression
19. Social controls on cell survival and cell death
20. Recent advances in the field of matrix metalloproteinase inhibitors
21. Stromelysin-3 expression promotes tumor take in nude mice
22. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy
23. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure
24. Cell staining
25. Immunology of spontaneous mammary carcinomas in mice
26. Regression models and life tables
27. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
28. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
29. The regulation of neovascularization by matrix metalloproteinases and their inhibitors
30. Histopathological evaluation of apoptosis in cancer
31. Stromelysin-3 is induced in tumor/stroma cocultures and inactivated via a tumor-specific and basic fibroblast growth factor-dependent mechanism
32. The extracellular matrix as a cell survival factor
33. Disruption of epithelial cell-matrix interactions induces apoptosis
34. rIFN-g-activated rat neutrophils induce tumor cell apoptosis by nitric oxide
35. Activation of caspase-3 (CPP32)-like proteases is essential for TNF-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model
36. Chemokines take center stage in inflammatory ills
37. The molecular basis of leukocytosis
38. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo
39. Demonstration in nude mice that stromelysin-3 functions through its proteolytic activity
40. Insulin-like growth factors and their binding proteins: Biological actions
41. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I
42. Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling
43. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro
44. Apoptosis in the pathogenesis and treatment of disease
45. Dr. Joseph Steiner cancer research prize lecture: The role of physiological cell death in neoplastic transformation and anticancer therapy